A stent and method of its use, the stent in its expanded configuration, exhibiting varying outward radial force along its length. In use, the expanded stent is of a tapered configuration which provides greater force in vessel regions requiring greater force and less force in regions requiring less. In particular the stent is useful in the ostium regions and at areas of bifurcation in vessels. Varying force over the length of the stent is achieved by varying the number of elements, the density of elements, the thickness of the elements making up the stent body, and maintaining a substantially metal to artery ratio in the expanded stent over its length.
|
1. A stent comprising a plurality of serpentine bands, adjacent serpentine bands being connected by a plurality of connections, the stent having a first end region, a second end region and a middle region disposed therebetween, the middle region spanning from the first end region to the second end region, each region comprising a plurality of serpentine bands, wherein the minimum number of connections between any two adjacent serpentine bands of the middle region is greater than the maximum number of connections between any two adjacent serpentine bands of the first end region.
13. A stent comprising a plurality of serpentine bands, each serpentine band comprising a plurality of proximal peaks and distal valleys connected by struts, serpentine bands which are adjacent to another connected one to the other via a plurality of connections, each connection connecting between a distal valley of one serpentine band and a proximal peak of an adjacent serpentine band, the stent having a first end region, a second end region and a middle region disposed therebetween, wherein the number of connections between adjacent serpentine bands increases from the first end region to the middle region.
2. The stent of
3. The stent of
4. The stent of
6. The stent of
10. The stent of
12. The stent of
14. The stent of
15. The stent of
16. The stent of
17. The stent of
18. The stent of
19. The stent of
|
This application is a Continuation application of U.S. application Ser. No. 10/703,642, filed Nov. 7, 2003, now U.S. Pat. No. 7,060,091, which is a Continuation application of U.S. application Ser. No. 10/301,983, filed Nov. 22, 2002, now U.S. Pat. No. 6,669,723, which is a continuation of U.S. application Ser. No. 09/735,398, filed Dec. 12, 2000, now U.S. Pat. No. 6,485,509 B2, issued Nov. 26, 2002, which is a continuation of U.S. application Ser. No. 09/314,658, filed May 19, 1999, now U.S. Pat. No. 6,159,238, issued Dec. 12, 2000 which is a divisional of U.S. application Ser. No. 09/034,249, filed Mar. 4, 1998, now U.S. Pat. No. 5,938,697, issued Aug. 17, 1999, the entire disclosures of which are hereby incorporated herein in their entireties by reference.
The invention relates generally to medical devices and their use. More specifically, the invention relates to stents for holding vessels such as arteries open to flow, particularly in the regions of bifurcations.
Stents are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. They have also been implanted in urinary tracts and bile ducts. They are used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding or expanded by an internal radial force, such as when mounted on a balloon.
Stents are generally tubular devices for insertion into tubular vessel regions. Balloon expandable stents require mounting over a balloon, positioning, and inflation of the balloon to expand the stent radially outward. Self-expanding stents expand into place when unconstrained, without requiring assistance from a balloon. A self-expanding stent is biased so as to expand upon release from the delivery catheter.
A vessel having a stenosis may be viewed as an inwardly protruding arcuate addition of hardened material to a cylindrical vessel wall, where the stenosed region presents a somewhat rigid body attached along, and to, the elastic wall. The stenosis presents resistance to any expansion of the vessel in the region bridged by the stenosis. Stenoses vary in composition, for example, in the degree of calcification, and therefore vary in properties as well.
The arcuate geometry of any stenoses present a variation in resistance along the vessel axis to stent outward radial force. Specifically, stenosed vessel resistance is often greatest toward the middle, lessening toward the ends, with a rapid decrease at the start of healthy vessel tissue.
In some instances, as in regions of bifurcation, stenoses are believed to be flow related phenomena, see Chapter 21 of the “Handbook of Bioengineering” (Richard Shaloh & Shu Chin, McGraw-Hill Book Company, 1987) which discusses atherosclerosis at vascular bifurcations.
The left and right common carotid arteries are typical of such vascular bifurcations. These arteries are the principal arteries of the head and neck. Both of the common carotid arteries are quite similar and divide at a carotid bifurcation or bulb into an external carotid artery and an internal carotid artery. In the region of the carotid bulb and the ostium of the internal carotid artery, stenoses present a particular problem for carotid stenting due to the large tapering of the vessel interior from the common carotid artery (both the left and the right) to the internal carotid artery. The region of the carotid bifurcation or bulb happens to be where stenoses most often occur, particularly in the region of the ostium to the internal carotid artery in both of the carotid arteries. Self-expanding stents are generally preferred for carotid stenting due to the anatomical location being subject to external compression.
A conventional self-expanding stent optimally has a length greater than the length of the stenosed region to be kept open. Current stents present a substantially uniform outward radial force and a uniform resistance to compression along their length. Currently, stents do not vary these forces to match vessel geometries or resistances. A constant force stent, i.e., prior art stents, with sufficient force to maintain an open channel within a stenosed vessel and to resist compression, has greater force than necessary in the healthy vessel portion distal to the stenosis. The stent end may thus flare outward, protruding into, and possibly irritating non-stenosed tissue.
Stenoses can occur in vessel regions having asymmetric geometry lying on either side of the stenosis. One example of this is the ostium of an internal carotid artery, having a wide opening converging into a narrower artery. A conventional stent placed in the region of the ostium would provide substantially uniform outward radial force over a non-uniform vessel diameter, that is, the force provided would be greater in a small diameter than in a larger diameter. If this force is properly matched for the smaller vessel region, it is likely less than optimal for the larger region. Conversely, if this force is properly matched for the larger vessel region, it is likely more than optimal for the smaller vessel region.
What would be desirable, and has not heretofore been provided, is a tapered stent capable of providing sufficient force to keep a vessel open within a rebounding stenosis, while providing only necessary force against healthy, non-stenosed vessel regions. What else has not been provided is a tapered stent providing necessary, but only necessary force (outward force and compression resistance) along a stenosis in a vessel region having non-uniform vessel diameter on either side of the stenosis. This is provided by the tapered stents of this invention which exhibit differing radial force, cell size, geometry, flexibility and which provide substantially more constant metal to artery ratio (M/A) over their length. MIA is the ratio of the metal surface area of a stent to the surface area of the vessel or the like that the stent is covering.
The present invention, in a preferred embodiment, includes a self-expanding stent of shape-memory metal having a tubular or cylindrical shaped structure in the unexpanded condition and a tapered tubular or cylindrical structure in the expanded or memorized condition, and in which the radial force varies longitudinally along the length of the stent. Also, its resistance to compression varies with length. Additionally, the cell design making up the stent is closed where force and good plaque coverage and support is required and open where flexibility is required. Additionally, the metal to artery ratio is substantially more constant over the length of the stent when it is expanded. One such stent is constructed of Nickel-Titanium alloy (nitinol). Other shape memory metals may be used. In one embodiment, the stent is constructed and arranged so that the outward radial force is greater in the center and lesser at both ends. In another embodiment, the stent is constructed and arranged so that the outward radial force is greater at one end and less at the opposite end. Such stents are suitable for placement in stenosed and narrowing vessel regions such as the carotid bifurcation and the ostial area associated therewith.
The stents of the invention may achieve a variation in radial force along their length by including in the stent structural elements which intersect at connections having more metal in regions requiring more radial force and less metal in regions requiring less radial force. The amount of intersection metal or strut member metal can be varied by varying the size of the intersection area or the size of the struts. Greater or fewer connectors actually are used to vary the flexibility along the length of the stent more than increasing radial force. In a preferred embodiment, the stent structure is formed by laser cutting a Nitinol tube, leaving a greater strut width and shorter length in regions requiring greater outward radial force and compression resistance.
The struts of the invention are also characterized by the fact that they are constructed and arranged to present a substantially more constant metal to artery ratio over their length in the expanded condition, i.e., expanded to a tapered shape.
The stent structure in a preferred embodiment includes a series of serpentine annular segments which are aligned to provide a tubular structure. The segments are interconnected longitudinally. A desired radial force can be varied by varying the stent strut dimensions in this and other embodiments. In one embodiment, stent regions requiring greater radial force have wider and shorter struts than regions requiring less force. The number of connectors between segments can also be varied for this purpose. It is also obtained by varying strut length and spacing and overall size. Another control is cell design per se. Closed cells provide greater plaque coverage and support than open cells. Closed cells are generally connected to cells in adjoining segments of the stent whereas open cells are not so connected. These factors also provide control over properties such as flexibility and conformability. Cell geometry, i.e., closed and open, is used to provide good plaque support in the region of the stenoses (closed) and less support (open) and more flexibility to either side of the stenoses. Also, closed cell structure may be used to bridge the origin of the external carotid artery or any other vessel side branch opening.
Generally speaking it is desirable to provide a stent of this invention with the aforementioned radial force which is variable over stent length in a predetermined arrangement; cell design which is closed in the area where the stent contacts plaque of a stenoses and more open where the stent contacts healthy vessel tissue; flexibility and conformability which is arranged to vary in a predetermined arrangement over the length of the stent, in both unexpanded and expanded condition.
Stents made in accordance with the present invention can provide an outward radial force more closely matching the local force requirements in a tapered vessel. In particular, the stents provide greater force only where required at a stenosis, without providing too much force in the region of healthy tissue. The stents provide an expanded geometry more closely tailored to the requirements of a tapering vessel region. They are preferably stiff and strong at the proximal large diameter end or middle and weak and more flexible at the distal smaller diameter end to provide strain relief and prevent kinking of the vessel distal to the stent. The proximal end may also be flexible.
A stent of the invention with variable properties along its length also applies to balloon expandable stents that can be used across bifurcations with large diameter change by dilating with a smaller balloon distally and a larger balloon proximally.
This invention is also concerned with a method for treating stenoses in vessel bifurcation regions involving the use of a stent of the type described above.
Referring now to
By starting with a stent of nitinol having the dimensions set forth in
A stent for use in this cross hatched region will have properties such as those to be described with reference to
Referring now to the
Similarly to the stent embodiment of
The present invention provides a stent which when expanded to its tapered configuration, provides a radial force varied along stent length for use in tapered anatomies. The stent has been described, in use, as bridging stenosed vessel regions for illustrative purposes. Another use in maintaining open channels through otherwise restricted body conduits. Stents used for other purposes are explicitly within the scope of the invention.
It should be noted that although self-expanding stents have been shown herein to illustrate the present invention, so called balloon expandable stents can also include the variable radial force feature as described herein. In the case of balloon expandable stents, however, these forces in general will be less than are necessary to expand the stent and thus the balloon will be used as known to those skilled in the art to complete the expansion of the stent. To obtain the tapered shape, two balloons of different diameter may be used to expand each end of the stent. These balloon expandable stents may be advantageously deployed in areas of a vessel such as at an ostium where a stent having more rigid or heavy members is desirable in the region of the stenosis, and enhanced flexibility in the distal portion of the stent is desired. For example, a balloon expandable stent can be made of stainless steel to the design and dimensions shown in either
In use, a stent of the self-expanding type, in unexpanded form, is placed on a delivery catheter and covered with a retractable sheath. The catheter is introduced into a vessel and advanced to a region of bifurcation (ostium or bifurcation placement). The sheath is retracted, typically by pulling it in the proximal direction, to expose the stent. The stent then self-expands to contact the vessel wall and stenosis. In the case of a self-expanding stent such as the nitinol type described herein, the stent expands to the tapered configuration upon being exposed and exhibits the desired proportion described hereinbefore. A sheath is typically used for constraining a self-expanding stent. A balloon expandable stent is typically crimped on to the balloon and not covered by a sheath. In the case of a non-self-expanding stent, a balloon or other radial force means is inflated within the stent to expand it. In the case of the stents described herein, two balloons may be used sequentially to accomplish this. For example, a small balloon may be used to expand the stent at the small diameter end of the tapered configuration. Then, a larger balloon may be used to expand the stents at the large end of the tapered configuration. The catheter(s) are withdrawn, leaving the stent implanted in the vessel. The method is adaptable depending on whether an ostial version or a bifurcation version of the stent is being implanted.
Numerous characteristics and advantages of the invention covered by this application have been set forth in the foregoing description. It will be understood, however, that this disclosure is, in many aspects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of parts and in materials without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Lininger, James R., Killion, Douglas P.
Patent | Priority | Assignee | Title |
10016211, | Oct 17 2007 | Covidien LP | Expandable tip assembly for thrombus management |
10028747, | May 01 2008 | Aneuclose LLC | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
10123803, | Oct 17 2007 | Covidien LP | Methods of managing neurovascular obstructions |
10271977, | Sep 08 2017 | VESPER MEDICAL, INC | Hybrid stent |
10413310, | Oct 17 2007 | Covidien LP | Restoring blood flow and clot removal during acute ischemic stroke |
10456151, | Feb 22 2008 | Covidien LP | Methods and apparatus for flow restoration |
10500078, | Mar 09 2018 | VESPER MEDICAL, INC | Implantable stent |
10512556, | Sep 08 2017 | VESPER MEDICAL, INC | Hybrid stent |
10588764, | Sep 08 2017 | Vesper Medical, Inc. | Hybrid stent |
10702405, | Mar 31 2016 | Vesper Medical, Inc. | Intravascular implants |
10716573, | May 01 2008 | Aneuclose LLC | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
10722255, | Dec 23 2008 | Covidien LP | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
10758381, | Mar 31 2016 | VESPER MEDICAL, INC | Intravascular implants |
10806560, | May 18 2015 | PULMAIR MEDICAL, INC | Implantable artificial bronchus and use of an implantable artificial bronchus |
10835257, | Oct 17 2007 | Covidien LP | Methods of managing neurovascular obstructions |
10849769, | Aug 23 2017 | VESPER MEDICAL, INC | Non-foreshortening stent |
11096773, | May 18 2015 | PULMAIR MEDICAL, INC | Implantable artificial bronchus and use of an implantable artificial bronchus |
11337714, | Oct 17 2007 | Covidien LP | Restoring blood flow and clot removal during acute ischemic stroke |
11344439, | Mar 09 2018 | Vesper Medical, Inc. | Implantable stent |
11357650, | Feb 28 2019 | VESPER MEDICAL, INC | Hybrid stent |
11364134, | Feb 15 2018 | VESPER MEDICAL, INC | Tapering stent |
11376142, | Sep 08 2017 | Vesper Medical, Inc. | Hybrid stent |
11484422, | Mar 31 2016 | Vesper Medical, Inc. | Intravascular implants |
11529156, | Feb 22 2008 | Covidien LP | Methods and apparatus for flow restoration |
11628075, | Mar 31 2016 | Vesper Medical, Inc. | Intravascular implants |
11628076, | Sep 08 2017 | VESPER MEDICAL, INC | Hybrid stent |
11786254, | Oct 17 2007 | Covidien LP | Methods of managing neurovascular obstructions |
7780719, | Mar 04 1998 | Boston Scientific Scimed, Inc. | Stent having variable properties and method of its use |
8066757, | Oct 17 2007 | Covidien LP | Blood flow restoration and thrombus management methods |
8070791, | Oct 17 2007 | Covidien LP | Multiple layer embolus removal |
8088140, | May 19 2008 | Covidien LP | Blood flow restorative and embolus removal methods |
8197493, | Oct 17 2007 | Covidien LP | Method for providing progressive therapy for thrombus management |
8226707, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
8545514, | Apr 11 2008 | Covidien LP | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
8574262, | Oct 17 2007 | Covidien LP | Revascularization devices |
8585713, | Oct 17 2007 | Covidien LP | Expandable tip assembly for thrombus management |
8679142, | Feb 22 2008 | Covidien LP | Methods and apparatus for flow restoration |
8685080, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
8852261, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
8926680, | Nov 12 2007 | Covidien LP | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
8940003, | Feb 22 2008 | Covidien LP | Methods and apparatus for flow restoration |
8945143, | Oct 17 2007 | Covidien LP | Expandable tip assembly for thrombus management |
8945172, | Oct 17 2007 | Covidien LP | Devices for restoring blood flow and clot removal during acute ischemic stroke |
9005272, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
9039756, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
9161766, | Feb 22 2008 | Covidien LP | Methods and apparatus for flow restoration |
9198687, | Oct 17 2007 | Covidien LP | Acute stroke revascularization/recanalization systems processes and products thereby |
9220522, | Oct 17 2007 | Covidien LP | Embolus removal systems with baskets |
9259314, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
9301860, | Mar 13 2013 | Edwards Lifesciences CardiAQ LLC | Articulated commissure valve stents and methods |
9320532, | Oct 17 2007 | Covidien LP | Expandable tip assembly for thrombus management |
9358140, | Nov 18 2009 | Aneuclose LLC | Stent with outer member to embolize an aneurysm |
9364323, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
9387098, | Oct 17 2007 | Covidien LP | Revascularization devices |
9700442, | Nov 11 2013 | Edwards Lifesciences CardiAQ LLC | Methods for manufacturing a stent frame |
9801714, | Jul 21 2008 | Edwards Lifesciences CardiAQ LLC | Repositionable endoluminal support structure and its applications |
9907684, | May 08 2013 | Aneuclose LLC | Method of radially-asymmetric stent expansion |
D902407, | Nov 19 2019 | PULMAIR MEDICAL, INC | Implantable artificial bronchus |
D954953, | Nov 03 2020 | PULMAIR MEDICAL, INC | Implantable artificial bronchus |
ER3576, | |||
ER5875, |
Patent | Priority | Assignee | Title |
4743251, | Dec 08 1983 | BOCQUEE, HENRY; GARDETTE, JACQUES | Vein prothesis and method for producing same |
5064435, | Jun 28 1990 | SciMed Life Systems, INC; Boston Scientific Scimed, Inc | Self-expanding prosthesis having stable axial length |
5383892, | Nov 08 1991 | MEADOX MEDICALS, INC | Stent for transluminal implantation |
5449373, | Mar 17 1994 | Medinol Ltd. | Articulated stent |
5575818, | Feb 14 1995 | Corvita Corporation | Endovascular stent with locking ring |
5649952, | Dec 28 1993 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
5683411, | Apr 06 1994 | Cook Medical Technologies LLC | Medical article for implantation into the vascular system of a patient |
5693086, | Feb 09 1994 | LIFEPORT SCIENCES LLC | Apparatus for delivering an endoluminal stent or prosthesis |
5707386, | Feb 04 1993 | ANGIOMED GMBH & CO MEDIZINTECHNIK KG | Stent and method of making a stent |
5725549, | Mar 11 1994 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
5741133, | Dec 07 1995 | Apparatuses and process for parallel placement of bone-integrated cylindrical type implants in dentistry | |
5741333, | Apr 12 1995 | Corvita Corporation | Self-expanding stent for a medical device to be introduced into a cavity of a body |
5755769, | Mar 12 1992 | W L GORE & ASSOCIATES INC | Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof |
5776162, | Jan 03 1997 | W L GORE & ASSOCIATES, INC | Vessel implantable shape memory appliance with superelastic hinged joint |
5800508, | Feb 09 1994 | LIFEPORT SCIENCES LLC | Bifurcated endoluminal prosthesis |
5800514, | May 24 1996 | LifeShield Sciences LLC | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
5807404, | Sep 19 1996 | MEDINOL LTD | Stent with variable features to optimize support and method of making such stent |
5817126, | Mar 17 1997 | NFOCUS NEUROMEDICAL, INC | Compound stent |
5817152, | Oct 19 1994 | Medtronic Ave, Inc | Connected stent apparatus |
5824059, | Aug 05 1997 | Flexible stent | |
5827321, | Feb 07 1997 | Endosystems, LLC | Non-Foreshortening intraluminal prosthesis |
5836966, | May 22 1997 | Boston Scientific Scimed, Inc | Variable expansion force stent |
5855600, | Aug 01 1997 | Boston Scientific Scimed, Inc | Flexible implantable stent with composite design |
5861027, | Apr 10 1996 | Variomed AG | Stent for the transluminal implantation in hollow organs |
5868780, | Mar 22 1996 | Medtronic Ave, Inc | Stents for supporting lumens in living tissue |
5868783, | Apr 16 1997 | NUMED, INC | Intravascular stent with limited axial shrinkage |
5876448, | May 08 1992 | SciMed Life Systems, INC; Boston Scientific Scimed, Inc | Esophageal stent |
5902317, | Jun 01 1994 | NMT MEDICAL, INC | Stent and method and apparatus for forming and delivering the same |
5913895, | Jun 02 1997 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Intravascular stent with enhanced rigidity strut members |
5922019, | Nov 27 1995 | Boston Scientific Corporation | Conical stent |
5938697, | Mar 04 1998 | Boston Scientific Scimed, Inc | Stent having variable properties |
5980552, | Mar 17 1994 | Medinol Ltd. | Articulated stent |
6017365, | May 20 1997 | Abbott Laboratories Vascular Enterprises Limited; Abbott Laboratories Vascular Entities Limited | Coronary stent |
6019789, | Apr 01 1998 | Boston Scientific Scimed, Inc | Expandable unit cell and intraluminal stent |
6022371, | Oct 22 1996 | Boston Scientific Scimed, Inc | Locking stent |
6027526, | Apr 10 1996 | Advanced Cardiovascular Systems, Inc. | Stent having varied amounts of structural strength along its length |
6068656, | May 15 1997 | Abbott Laboratories Vascular Enterprises Limited; Abbott Laboratories Vascular Entities Limited | Coronary stent |
6071298, | Mar 22 1996 | Medtronic Ave, Inc | Stents for supporting lumens in living tissue |
6106548, | Feb 07 1997 | Endosystems LLC | Non-foreshortening intraluminal prosthesis |
6129754, | Dec 11 1997 | UNI-CATH INC | Stent for vessel with branch |
6132461, | Mar 27 1998 | EV3 PERIPHERAL, INC | Stent with dual support structure |
6159237, | Feb 14 1996 | Boston Scientific Scimed, Inc | Implantable vascular and endoluminal stents |
6159238, | Mar 04 1998 | Boston Scientific Scimed, Inc | Stent having variable properties and method of its use |
6179867, | Jan 16 1998 | Advanced Cardiovascular Systems, Inc. | Flexible stent and method of use |
6190406, | Jan 09 1998 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Intravascular stent having tapered struts |
6231598, | Sep 24 1997 | Cook Medical Technologies LLC | Radially expandable stent |
6264687, | Apr 20 1998 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Multi-laminate stent having superelastic articulated sections |
6273910, | Mar 11 1999 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
6342057, | Apr 28 2000 | Synthes USA, LLC | Remotely aligned surgical drill guide |
6342067, | Jan 09 1998 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Intravascular stent having curved bridges for connecting adjacent hoops |
6475236, | Feb 07 1997 | Endosystems, LLC | Non-foreshortening intraluminal prosthesis |
6485509, | Mar 04 1998 | Boston Scientific Scimed, Inc | Stent having variable properties and method of its use |
6503271, | Jan 09 1998 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Intravascular device with improved radiopacity |
6562067, | Jun 08 2001 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Stent with interlocking elements |
6669723, | Mar 04 1998 | Boston Scientific Scimed, Inc | Stent having variable properties and method of its use |
EP688545, | |||
EP824902, | |||
EP830853, | |||
EP796597, | |||
WO9518585, | |||
WO9737617, | |||
WO9852497, | |||
WO9415548, | |||
WO9625124, | |||
WO9725937, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 01 2005 | SciMed Life Systems, INC | Boston Scientific Scimed, Inc | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 018505 | /0868 | |
Feb 17 2006 | Boston Scientific Scimed, Inc. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Jun 23 2008 | ASPN: Payor Number Assigned. |
Sep 23 2011 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Jan 06 2016 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Mar 09 2020 | REM: Maintenance Fee Reminder Mailed. |
Aug 24 2020 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Jul 22 2011 | 4 years fee payment window open |
Jan 22 2012 | 6 months grace period start (w surcharge) |
Jul 22 2012 | patent expiry (for year 4) |
Jul 22 2014 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 22 2015 | 8 years fee payment window open |
Jan 22 2016 | 6 months grace period start (w surcharge) |
Jul 22 2016 | patent expiry (for year 8) |
Jul 22 2018 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 22 2019 | 12 years fee payment window open |
Jan 22 2020 | 6 months grace period start (w surcharge) |
Jul 22 2020 | patent expiry (for year 12) |
Jul 22 2022 | 2 years to revive unintentionally abandoned end. (for year 12) |